Literature DB >> 17600653

Tailored treatment in the outpatient substance abuse treatment sector: 1995-2005.

Jeffrey A Alexander1, Tammie A Nahra, Christy Harris Lemak, Harold Pollack, Cynthia I Campbell.   

Abstract

Interest in improving the quality of addiction treatment has led to the development of clinical paradigms that emphasize the principle of tailored care-matching treatments to the specific needs of each client or client subgroup. This work analyzes how trends in the provision of tailored treatment practices (TTPs) have changed between 1995 and 2005 across outpatient substance abuse treatment (OSAT) programs in the United States. Categories of interest include measures to capture needs assessment and treatment planning activities, treatment offerings for special populations, and case management activities. Results show that TTPs have diffused in an uneven fashion in the population of OSAT programs between 1995 and 2005. Specifically, needs assessment/treatment planning and case management remain a relatively common practice among OSAT programs, while treatment for special populations (especially same-race therapy) is less widely practiced and, indeed, experienced some decline over the study period. This trend is troublesome given that minority clients constitute a large proportion of those utilizing OSAT programs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17600653     DOI: 10.1016/j.jsat.2007.04.009

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  11 in total

1.  Application of multivariate probabilistic (Bayesian) networks to substance use disorder risk stratification and cost estimation.

Authors:  Lawrence Weinstein; Todd A Radano; Timothy Jack; Philip Kalina; John S Eberhardt
Journal:  Perspect Health Inf Manag       Date:  2009-09-16

2.  Predictors of change in the provision of services within outpatient substance abuse treatment programs.

Authors:  Danica Kalling Knight; Jennifer R Edwards; Patrick M Flynn
Journal:  J Public Health Manag Pract       Date:  2010 Nov-Dec

3.  Organizational correlates of service availability in outpatient substance abuse treatment programs.

Authors:  Jennifer R Edwards; Danica K Knight; Patrick M Flynn
Journal:  J Behav Health Serv Res       Date:  2011-10       Impact factor: 1.505

4.  Workforce diversity in outpatient substance abuse treatment: the role of leaders' characteristics.

Authors:  Erick G Guerrero
Journal:  J Subst Abuse Treat       Date:  2012-06-02

5.  Treatment needs of men and women with violence problems in substance use disorder treatment.

Authors:  Stephen T Chermack; Regan L Murray; Jamie J Winters; Maureen A Walton; Brenda M Booth; Frederic C Blow
Journal:  Subst Use Misuse       Date:  2009       Impact factor: 2.164

6.  Organizational determinants of outpatient substance abuse treatment duration in women.

Authors:  Cynthia I Campbell; Jeffrey A Alexander; Christy Harris Lemak
Journal:  J Subst Abuse Treat       Date:  2008-11-26

7.  Substance use and hepatitis C: an ecological momentary assessment study.

Authors:  Karran A Phillips; David H Epstein; Massoud Vahabzadeh; Mustapha Mezghanni; Jia-Ling Lin; Kenzie L Preston
Journal:  Health Psychol       Date:  2014-07       Impact factor: 4.267

8.  Availability of substance abuse treatment services in Spanish: a GIS analysis of Latino communities in Los Angeles County, California.

Authors:  Erick G Guerrero; Karen B Pan; Andrew Curtis; Erica L Lizano
Journal:  Subst Abuse Treat Prev Policy       Date:  2011-08-12

9.  Tailoring services in opioid treatment programs for patients involved in America's criminal justice system: national associations and variation by state and Medicaid expansion status.

Authors:  George Pro; Brooke E E Montgomery; Nickolas Zaller
Journal:  Subst Abuse Treat Prev Policy       Date:  2021-06-19

10.  Patient-centred care for addiction treatment: a scoping review protocol.

Authors:  Kirsten Marchand; Scott Beaumont; Jordan Westfall; Scott MacDonald; Scott Harrison; David C Marsh; Martin T Schechter; Eugenia Oviedo-Joekes
Journal:  BMJ Open       Date:  2018-12-27       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.